Epivara, Inc. received a $254,760 Project Grant award from the National Science Foundation Division of Industrial Innovation under the Engineering federal grant program (CFDA 47.041) to develop a safe and effective injectable alternative to surgical spays in female dogs. The award period runs from May 1, 2021 through April 30, 2022. The Engineering program seeks to improve quality of life and economic strength through fostering innovation in engineering research and education. This award will...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Cooperative Agreement award of $1,000,000 supports the development of a "living pharmacy" technology to treat diabetes and obesity in cats. The project aims to demonstrate the safety and tolerability of a novel, potentially harmless universal designer organism as a living pharmacy that can effectively control blood glucose and weight gain in companion animals with a single injection for up...
This Project Grant award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $274,999 to Therafluor Inc. to develop a low-cost multimodal medical instrument for cancer diagnosis and treatment in companion animals. The instrument aims to visualize, target, and effectively eliminate cancerous cells in pets by utilizing a proprietary molecular therapeutic compound, silicon naphthalocyanine nanoparticle (SINC-NP). The...
This Project Grant award of $474,946 from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) supports the development of a novel, drug-free, female-initiated contraceptive technology. The key products or services to be delivered under this grant include: Design and fabrication of a dual-compartment vaginal device that enables women to administer a bioresponsive polymer fiber mat and supplemental fluid to fortify...
Hera Health Solutions Inc. received a $275,000 National Science Foundation Project Grant under the NSF Technology, Innovation, and Partnerships program to develop a biodegradable contraceptive-releasing implant. The award aims to advance long-acting reversible contraception by creating an implant that delivers consistent hormone doses and does not require surgical removal. During the one-year period from May 1, 2023 to April 30, 2024, the company will characterize the drug delivery scaffold,...
This National Science Foundation (NSF) Project Grant award of $275,000 to Zealous Research LLC is part of the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program. The project aims to develop a single-chip microfluidic platform to automate and optimize in vitro fertilization (IVF) processes, including sperm selection, sperm capacitation, and egg fertilization. The goal is to create a user-friendly, affordable, and high-throughput platform that can increase IVF success rates and...
This $254,580 National Science Foundation Technology, Innovation, and Partnerships project grant funds the development of artificial intelligence-mediated orthopedic implant design and selection software by Med Dimensions, LLC. The Phase I small business innovation research project aims to create a machine learning system that incorporates bone density screening and 2D to 3D reconstruction to generate anatomically-derived implants and guide implant placement for veterinary use. By integrating...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award provides $294,996 to Semen And Embryo Advanced Reproductive Technologies (Smart), LLC to develop machine learning models and computer vision systems to improve small ruminant (sheep and goat) breeding success rates through computer-assisted embryo analysis. The project aims to accelerate the quality and growth of U.S. small ruminant production by democratizing embryo transfer...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $273,652 to Phage Refinery LLC aims to develop a rapid and efficient parametric model for predicting the likelihood that a given bacteriophage (phage) will survive sufficiently long in the presence of an active immune system to be effective as a treatment against their target bacterial infection. The project will gather physical parameters and in-vivo persistence data for 400...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) Project Grant award of $295,000 to Theracea Pharma LC aims to develop innovative 18F-radiotracer kits for detecting biomarkers using Positron Emission Tomography (PET) imaging. The project will leverage advancements in chemistry and biology to design cutting-edge diagnostic products for applications in preclinical research and clinical diagnostics, particularly in the field of oncology....